It functions as a dual GLP-1 and GIP receptor agonist , offering: Enhanced insulin secretion Delayed gastric emptying Appetite suppression Improved glycemic control Tirzepatide demonstrated impressive clinical outcomes in the SURMOUNT and SURPASS trials, with average weight loss of 15-22.5% and substantial A1C reductions
Lip Fillers Plump and shape your lips for a soft, kissable pout
For Patients Concerned About Cost: Metformin is a good option as it is inexpensive, has been used for many years, and has a good safety profile
Mikami T, Sumida S, Ishibashi Y, Ohta S
17: Tentolouris A, Siafarikas C, Ntanasis-Stathopoulos I, Anastasiou IA, Kalara E, Briasoulis A
Park J R, Lee H, Kim S I, et al